Technical Analysis for PCRX - Pacira Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
A 63.59 0.87% 0.55
PCRX closed up 0.87 percent on Friday, May 20, 2022, on 66 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Up

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Crossed Above 200 DMA Bullish 0.87%
Wide Bands Range Expansion 0.87%
Fell Below 200 DMA Bearish 3.55%
Wide Bands Range Expansion 3.55%
Gapped Down Weakness 3.55%
1,2,3 Retracement Bearish Bearish Swing Setup 0.02%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.02%
200 DMA Support Bullish 0.02%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% about 16 hours ago
60 Minute Opening Range Breakdown about 18 hours ago
Rose Above Previous Day's High about 19 hours ago
Up 1% about 19 hours ago
Rose Above Previous Day's High 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pacira Pharmaceuticals, Inc. Description

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers worldwide. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company markets EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic, indicated for administration into the surgical site to produce postsurgical analgesia; and DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a cancer of the immune system. Its product pipeline comprise EXPAREL that has completed Phase II clinical trials for postsurgical analgesia-nerve block administration; DepoNSAID, which is in preclinical trials for the relief of acute pain; and DepoMethotrexate that is in preclinical trials for the treatment of rheumatoid arthritis and oncology, as well as Bupivacaine Liposome Injectable Suspension for veterinary postsurgical analgesia. Pacira Pharmaceuticals, Inc. has a development and commercialization agreement, and related supply agreement with Aratana Therapeutics, Inc. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Pharmaceutical Immune System Pain Surgery Pharmaceutical Products IBD 50 Lymphoma Pharmacology Rheumatoid Arthritis Dosage Forms Drug Delivery Suspension Nerve Acute Pain Piperidines Bupivacaine Drug Delivery Technology Meningitis Methotrexate Liposome Local Anesthetic Surgical Site

Is PCRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 82.1593
52 Week Low 45.05
Average Volume 532,873
200-Day Moving Average 61.89
50-Day Moving Average 71.76
20-Day Moving Average 66.77
10-Day Moving Average 61.76
Average True Range 2.84
RSI 40.48
ADX 33.41
+DI 14.63
-DI 27.91
Chandelier Exit (Long, 3 ATRs) 68.43
Chandelier Exit (Short, 3 ATRs) 67.25
Upper Bollinger Bands 78.90
Lower Bollinger Band 54.63
Percent B (%b) 0.37
BandWidth 36.35
MACD Line -3.03
MACD Signal Line -2.99
MACD Histogram -0.0378
Fundamentals Value
Market Cap 2.76 Billion
Num Shares 43.4 Million
EPS 2.93
Price-to-Earnings (P/E) Ratio 21.70
Price-to-Sales 6.33
Price-to-Book 4.61
PEG Ratio -3.83
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 66.80
Resistance 3 (R3) 66.61 65.36 66.27
Resistance 2 (R2) 65.36 64.54 65.45 66.09
Resistance 1 (R1) 64.47 64.03 63.85 64.66 65.91
Pivot Point 63.22 63.22 62.90 63.31 63.22
Support 1 (S1) 62.33 62.40 61.71 62.52 61.27
Support 2 (S2) 61.08 61.89 61.17 61.09
Support 3 (S3) 60.19 61.08 60.92
Support 4 (S4) 60.38